EXTRAHEPATIC CHOLANGIOCARCINOMA AND GALLBLADDER CARCINOMA

Clinical trials for EXTRAHEPATIC CHOLANGIOCARCINOMA AND GALLBLADDER CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new EXTRAHEPATIC CHOLANGIOCARCINOMA AND GALLBLADDER CARCINOMA trials appear

Sign up with your email to follow new studies for EXTRAHEPATIC CHOLANGIOCARCINOMA AND GALLBLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy aims to stop bile duct cancer return after surgery

Disease control Recruiting now

This study is testing whether giving chemotherapy (capecitabine or S-1) together with radiation after surgery can help prevent bile duct and gallbladder cancers from coming back. It includes 92 patients whose cancers had high-risk features, like positive lymph nodes or narrow sur…

Matched conditions: EXTRAHEPATIC CHOLANGIOCARCINOMA AND GALLBLADDER CARCINOMA

Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

EXTRAHEPATIC CHOLANGIOCARCINOMA AND GALLBLADDER CARCINOMA

Get alerted when new EXTRAHEPATIC CHOLANGIOCARCINOMA AND GALLBLADDER CARCINOMA trials appear

New combo therapy aims to stop bile duct cancer return after surgery